Lived Experiences and Daily Life Fatigue among Non-Medical Prescribed Opioid Users in Pakistan: A Thematic Analysis
Keywords:Daily Life Fatigues, Lived Experiences, Opioids
The misuse of opioids for non-medical purposes is a persistent public health concern worldwide, particularly in developing countries like Pakistan, where a considerable number of individuals experiences the deleterious physiological and psychological consequences stemming from this behavior. The primary aim of the study was to assess the personal experiences and fatigue levels of individuals engaging in non-medical opioid use. The data were collected from addiction, and rehabilitation centers and the sample consisted of 12 individuals both males and females, who aged from 18 to 60 years (M=27.64, SD=9.10). Additionally, individuals who were actively involved in non-medical opioid usage were included in the study. These individuals were assessed through the utilization of a semi-structured interview approach, providing a balanced framework that allowed for both predetermined questions and open-ended inquiries to gather comprehensive information. The finding reveals that various factors, including physical and mental health issues, family dynamics, and peer influence, contribute to opioid consumption. The study identifies a wide range of symptoms, from psychological and physical effects to dependency and isolation. Moreover, rehabilitation efforts may be affected by factors such as individual motivation and familial support, while the lack of awareness about addiction treatability serves as an inhibitory factor. Although the use of opioids can initially cause feelings of pleasure, relaxation, and heightened energy akin to manic symptoms, it frequently leads to detrimental psychological outcomes. These adverse effects include impulsive actions, guilt, and disruption in daily routines.
Abuse, S. (2006). Results from the 2005 National Survey on Drug Use and Health: National Findings. Department of Health and Human Services, Substance Abuse and Mental Health. https://www.samhsa.gov
Afridi, M. I. (2017). A survey to determine motivating factors to quit opioids in treatment seekers at a tertiary care hospital. Journal of the Pakistan Medical Association, 67, 1050-1053.
Ballantyne, J. C., & Sullivan, M. D. (2017). Discovery of endogenous opioid systems: what it has meant for the clinician's understanding of pain and its treatment. Pain, 158(12), 2290-2300. https://doi.org/10.1097/j.pain.0000000000001043 DOI: https://doi.org/10.1097/j.pain.0000000000001043
Cheung, C. K., Cheung, H. Y., Wu, J., & youth. (2014). Career unreadiness in relation to anxiety and authoritarian parenting among undergraduates. International Journal of Adolescence, 19(3), 336-349. https://doi.org/10.1080/02673843.2014.928784 DOI: https://doi.org/10.1080/02673843.2014.928784
Cicero, T. J., Ellis, M. S., & Harney, J. (2015). Shifting patterns of prescription opioid and heroin abuse in the United States. New England Journal of Medicine, 373(18), 1789-1790. DOI: https://doi.org/10.1056/NEJMc1505541
Coffa, D., & Snyder, H. (2019). Opioid use disorder: medical treatment options. American Family Physician, 100(7), 416-425.
Compton, W. M., Boyle, M., & Wargo, E. (2015). Prescription opioid abuse: problems and responses. Preventive Medicine, 80, 5-9. https://doi.org/10.1016/j.ypmed.2015.04.003 DOI: https://doi.org/10.1016/j.ypmed.2015.04.003
Ghazal, P. (2019). Rising trend of substance abuse in Pakistan: a study of sociodemographic profiles of patients admitted to rehabilitation centres. Public health, 167, 34-37. https://doi.org/10.1016/j.puhe.2018.10.020 DOI: https://doi.org/10.1016/j.puhe.2018.10.020
Grusec, J. E. (1994). Social learning theory and developmental psychology: The legacies of Robert R. Sears and Albert Bandura. Devlopmental Psychology, 28(5), 776-786. DOI: https://doi.org/10.1037/0012-16220.127.116.116
Janz, N. K., & Becker, M. H. (1984). The health belief model: A decade later. Health Education & Behavior, 11(1), 1-47. https://doi.org/10.1177/109019818401100101 DOI: https://doi.org/10.1177/109019818401100101
Johnston, L., Miech, R., O'Malley, P., Bachman, J., Schulenberg, J., & Patrick, M. (2022). Monitoring the Future national survey results on drug use, 1975-2021: Overview, key findings on adolescent drug use. https://dx.doi.org/10.7302/4142 DOI: https://doi.org/10.3998/2027.42/162579
Kiger, M. E., & Varpio, L. (2020). Thematic analysis of qualitative data: AMEE Guide No. 131. Medical Teacher, 42(8), 846-854. https://doi.org/10.1080/0142159X.2020.1755030 DOI: https://doi.org/10.1080/0142159X.2020.1755030
Lall, S., & Paul, R. (2001). Measure to Reduce Non-Medical Use of Prescription Drugs in South Asia. Chapter, 12, 205-215.
Li, D. H., & Mustanski, B. (2018). Prevalence and correlates of prescription drug misuse among a racially diverse sample of young sexual minority men. LGBT Health, 5(2), 95-104. https://doi.org/10.1089/lgbt.2017.0125 DOI: https://doi.org/10.1089/lgbt.2017.0125
Light, D. (2010). The risks of prescription drugs. Columbia University Press. DOI: https://doi.org/10.7312/ligh14692
Madras, B. K. (2017). The surge of opioid use, addiction, and overdoses: responsibility and response of the US health care system. JAMA Psychiatry, 74(5), 441-442. https://doi.org/10.1001/jamapsychiatry.2017.0163 DOI: https://doi.org/10.1001/jamapsychiatry.2017.0163
Majid, Z., Tanveer, M., Asghar, S. A., Tahir, F., Minhaj, A., Khan, H. A., Sialvi, T., Mahmood, S. H., Qadar, L. T.,& Imtiaz, F. (2019). Opioids use and abuse: Prescription practice, attitude, and beliefs among Doctors of Karachi. Cureus, 11(7). DOI: 10.7759/cureus.5253 DOI: https://doi.org/10.7759/cureus.5253
O'Brien, T., Christrup, L., Drewes, A., Fallon, M., Kress, H., McQuay, H., Mikus, G., Morlion, B. J., Perez-Cajaraville, J., Pogatzki-Zahn, E., Varrassi, G., & Wells, J. C. D. (2017). European Pain Federation position paper on appropriate opioid use in chronic pain management. European Journal of Pain, 21(1), 3-19. https://doi.org/10.1002/ejp.970 DOI: https://doi.org/10.1002/ejp.970
Peteet, B. J. (2019). Psychosocial risks of prescription drug misuse among US racial/ethnic minorities: A systematic review. Journal of Ethnicity in Substance Abuse, 18(3), 476-508. https://doi.org/10.1080/15332640.2017.1381662 DOI: https://doi.org/10.1080/15332640.2017.1381662
Preuss, C. V., Kalava, A., & King, K. C. (2019). Prescription of controlled substances: benefits and risks. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK537318/
Sabzwari, S., Kumar, D., Bhanji, S., Sheerani, M., & Azhar, G. (2014). Proportion, predictors and outcomes of delirium at a tertiary care hospital in Karachi, Pakistan. Ageing International, 39, 33-45. DOI: https://doi.org/10.1007/s12126-012-9152-5
Volkow, N. D. (2014). Prescription opioid and heroin abuse. National Institute on Drug Abuse. https://www.nih.gov/sites/default/files/institutes/olpa/20140514-senate-testimony-volkow.pdf
Yaqub, F. (2013). Pakistan's drug problem. The Lancet, 381(9884), 2153-2154. https://doi.org/https://doi.org/10.4324/9780203977460 DOI: https://doi.org/10.1016/S0140-6736(13)61426-9
Zaman, S., Hussain, B., Irfan, S., Khattak, A. Z., & Shaheen, A. (2022). Sociodemographic characteristics and related factors of substance use in Pakistan; a retrospective study. Journal of Substance Use,1-6. https://doi.org/10.1080/14659891.2022.2139304 DOI: https://doi.org/10.1080/14659891.2022.2139304
Zaman, S., & Irfan, S. (2020). Surging use of prescribed opioids among the Pakistani population. The Journal of the Pakistan Medical Association, 70(7), 1294-1294. DOI: https://doi.org/10.5455/JPMA.78568
Zaman, S., Irfan, S., Hussain, B., Nawaz, M. T., & Khalid, S. (2020). Cross-cultural insights on lived experiences of opioid users among young adults. Drugs & Alcohol Today, 20(2), 85-93. DOI: https://doi.org/10.1108/DAT-03-2020-0014
How to Cite
Copyright (c) 2023 Rizwan Ullah, Sabir Zaman , Muhammad Muslim Khan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) License: This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International License (https://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-Commercial use, reproduction
and distribution of the work without further permission provided the original work is attributed as specified on the Journal website at (https://iprpk.com/ojs/index.php/jpap)